This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
MOUSE ANTI HUMAN CD45:FITC
catalog :
MCA1719F
quantity :
0.1 mg
price :
316 USD
clonality :
monoclonal
host :
mouse
conjugate :
FITC
clone name :
HI30
reactivity :
human
application :
flow cytometry
product information
Entity Type :
Monoclonal Antibody
Entity Category :
Antibodies
ProductCode :
MCA1719F
Description :
MOUSE ANTI HUMAN CD45:FITC
Specificity :
CD45
TargetSpecies :
Human
Host :
Mouse
Format :
FITC
Conjugate/Tag :
FITC
Isotypes :
IgG1
Applications :
F
ApplicationTypes :
Flow Cytometry
Cross Reactivities :
Chimpanzee
Clone :
HI30
Quantity :
0.1 mg
Quantity Value :
0.1
Quantity Type :
mg
GO Accessions :
GO:0051607,GO:0051209,GO:0050857,GO:0050853,GO:0050852,GO:0045121,GO:0042100,GO:0030890,GO:0033261,GO:0001960,GO:0001915,GO:0019901,GO:0007411,GO:0006470,GO:0006469,GO:0005925,GO:0005887,GO:0005001,GO:0002378
GOTerms :
down regulation of T cell mediated cytotoxicity,downregulation of T cell mediated cytotoxicity,down-regulation of T cell mediated cytotoxicity,inhibition of T cell mediated cytotoxicity,negative regulation of T cell mediated apoptosis,negative regulation of T cell mediated cell death,negative regulation of T cell mediated cell killing,negative regulation of T cell mediated cytolysis,negative regulation of T lymphocyte mediated cytotoxicity,negative regulation of T-cell mediated apoptosis,negative regulation of T-cell mediated cell death,negative regulation of T-cell mediated cell killing,negative regulation of T-cell mediated cytolysis,negative regulation of T-cell mediated cytotoxicity,negative regulation of T-lymphocyte mediated cytotoxicity,down regulation of cytokine mediated signaling pathway,downregulation of cytokine mediated signaling pathway,down-regulation of cytokine mediated signaling pathway,inhibition of cytokine mediated signaling pathway,negative regulation of cytokine and chemokine mediated signaling pathway,negative regulation of cytokine mediated signaling pathway,negative regulation of cytokine mediated signalling pathway,antibody biosynthesis,antibody biosynthetic process,focal contact,GO:0008357,hemi-adherens junction,down regulation of protein kinase activity,downregulation of protein kinase activity,down-regulation of protein kinase activity,inhibition of protein kinase activity,protein amino acid dephosphorylation,axon chemotaxis,axon growth cone guidance,axon pathfinding,GO:0008040,activation of B cell proliferation,positive regulation of B lymphocyte proliferation,positive regulation of B-cell proliferation,positive regulation of B-lymphocyte proliferation,stimulation of B cell proliferation,up regulation of B cell proliferation,upregulation of B cell proliferation,up-regulation of B cell proliferation,regulation of progression through S phase,regulation of S-phase,B lymphocyte proliferation,B-cell proliferation,B-lymphocyte proliferation,GO:0042114,GEM domain,glycolipid-enriched membrane domain,lipid raft,T lymphocyte receptor signaling pathway,T lymphocyte receptor signalling pathway,T-cell receptor signaling pathway,T-cell receptor signalling pathway,TCR signaling pathway,T-lymphocyte receptor signaling pathway,T-lymphocyte receptor signalling pathway,B cell receptor signalling pathway,B lymphocyte receptor signaling pathway,B lymphocyte receptor signalling pathway,B-cell receptor signaling pathway,B-cell receptor signalling pathway,B-lymphocyte receptor signaling pathway,B-lymphocyte receptor signalling pathway,activation of antigen receptor-mediated signaling pathway,positive regulation of antigen receptor mediated signalling pathway,stimulation of antigen receptor-mediated signaling pathway,up regulation of antigen receptor-mediated signaling pathway,up-regulation of antigen receptor-mediated signaling pathway,upregulation of antigen receptor-mediated signaling pathway,calcium ion (Ca2+) mobilization,calcium mobilization,cytoplasmic release of sequestered calcium ion (Ca2+),cytoplasmic release of stored calcium ion (Ca2+),cytosolic release of sequestered calcium ion (Ca2+),cytosolic release of stored calcium ion (Ca2+),release of sequestered calcium ion (Ca2+),release of sequestered calcium ion into cytoplasm,release of stored calcium ion (Ca2+),release of stored calcium ion (Ca2+) into cytoplasm,release of stored calcium ion (Ca2+) into cytosol,antiviral response,defence response to virus,defense response to viruses
Uniprot Accessions :
P08575
Gene :
PTPRC
GeneID URL :
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=5788
Published Synonyms :
LCA
Entity Formats :
APC,FITC,PE-Texas Red®,Purified,RPE,RPE-CY5
UNSPSC :
41116161
Concentration :
IgG concentration 0.5 mg/ml
Product Form :
Purified IgG conjugated to Fluorescein Isothiocyanate Isomer 1 (FITC) - liquid
PriceGBP :
225
PriceEUR :
316
PriceUSD :
316 USD
PriceCHF :
344
PriceSEK :
3444
PriceNOK :
3462
PriceDKK :
2356
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com
1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.